This retrospective cross-sectional analysis of pharmacy data indicates that most buprenorphine prescribers’ patient censuses are considerably below current limits.
This noninferiority trial compares the effects of implanted vs sublingual buprenorphine for sustaining abstinence among adults with opioid dependence who achieved abstinence after 6 months or more of sublingual buprenorphine treatment.
This JAMA Clinical Guidelines Synopsis summarizes the British Columbia Ministry of Health’s 2015 guidelines on clinical management of opioid use disorder in adults.
This study used National Survey of Drug Use and Health data to assess substance use treatment trends among individuals aged 12 years or older with opioid use disorders.
A randomized trial involving opioid-dependent patients found that buprenorphine treatment with coordinated follow-up for ongoing treatment was more effective than referral with or without brief intervention.